Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Protalix Ltd.”

22 pharma patents match "Protalix Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 22
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 22 pharmaceutical patents matching "Protalix Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

22 results for “Protalix Ltd.” · 30,257 patents in full index Clear search

  1. US 12385026

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 12194079

    Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

    Protalix Ltd. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  3. US 11814657

    Modified DNase and uses thereof

    Protalix Ltd. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  4. US 11225648

    Modified DNase and uses thereof

    Protalix Ltd. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  5. US 10870842

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  6. US 10730925

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  7. US 10280414

    Stabilized α-galactosidase and uses thereof

    Protalix Ltd. · Granted May 7, 2019 · Expires May 2, 2039

    granted
  8. US 10087232

    Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

    Protalix Ltd. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  9. US 10000551

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  10. US 9732333

    Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

    Protalix Ltd. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  11. US 9708595

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  12. US 9603906

    Inhalable liquid formulations of DNase I

    Protalix Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  13. US 9603907

    Dry powder formulations of dNase I

    Protalix Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  14. US 9220737

    Plant cell culture expressing human lysosomal proteins and uses thereof

    Protalix Ltd. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  15. US 9194011

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  16. US 8790641

    Production of high mannose proteins in plant culture and therapeutic uses thereof

    Protalix Ltd. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  17. US 8742079

    Saccharide-containing protein conjugates and uses thereof

    Protalix Ltd. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  18. US 8741620

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  19. US 8449876

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 28, 2013 · Expires May 23, 2033

    granted
  20. US 8227230

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  21. US 7951557

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  22. US 7655781

    Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

    Protalix Ltd. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted